TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
NeuroGyn Norr AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
682
|
1,457
|
1,945 |
Financial expenses |
146
|
116
|
140 |
Earnings before taxes |
-330
|
-341
|
68 |
EBITDA |
-184
|
-217
|
212 |
Total assets |
662
|
984
|
1,333 |
Current assets |
526
|
786
|
1,126 |
Current liabilities |
499
|
741
|
649 |
Equity capital |
163
|
243
|
660 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
1
|
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
24.6%
|
24.7%
|
49.5% |
Turnover per employee |
682
|
728
|
972 |
Profit as a percentage of turnover |
-48.4%
|
-23.4%
|
3.5% |
Return on assets (ROA) |
-27.8%
|
-22.9%
|
15.6% |
Current ratio |
105.4%
|
106.1%
|
173.5% |
Return on equity (ROE) |
-202.5%
|
-140.3%
|
10.3% |
Change turnover |
-775
|
-488
|
-172 |
Change turnover % |
-53%
|
-25%
|
-8% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-50%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.